Radhakrishnan Srikanth 4

What Happened

• Radhakrishnan Srikanth, Pulmonx's Chief Science & Technology Officer, reported four sales on 2026-06-01 totaling 14,497 shares at $1.54 per share (approx. $22,325). The reported disposals:
  • 2,691 shares @ $1.54 = $4,144
  • 2,153 shares @ $1.54 = $3,316
  • 3,684 shares @ $1.54 = $5,673
  • 5,969 shares @ $1.54 = $9,192
• These were sales (code S) to satisfy tax withholding obligations tied to the vesting of Restricted Stock Units (RSUs), not open-market purchases.

Key Details

• Transaction date: 2026-06-01; reported filing date: 2026-06-03 (appears timely — within the typical two business-day Form 4 window).
• Price per share: $1.54; total shares sold: 14,497; total proceeds: ≈ $22,325.
• Footnotes: sales were to cover tax withholding for RSUs granted on 3/1/2023 (F1), 3/1/2024 (F2), 3/3/2025 (F3) and 3/2/2026 (F4).
• Shares owned after the transaction are not specified in the provided filing summary.

Context

• These transactions are routine tax-withholding sales following RSU vesting and do not necessarily indicate a change in the insider’s view of the company. Sales to cover withholding are common and generally not treated the same as discretionary open-market selling by insiders.